Clinically, SMARCA4-deficient non-small cell lung carcinoma (SMARCA4-dNSCLC) were associated with the poorly differentiated histologic manifestations and poor prognosis. This evidence concerns the gene SMARCA4 and non-small cell lung carcinoma.